DEA Training: Overview of Suboxone Usage In Opioid Use Disorder During Pregnancy
Update: 2023-10-30
Description
Brittany Parker, MD NGPG Family Medicine
Tembele Yangandawele, MD NGPG Family Medicine
No Disclosures
Objectives:
•Review epidemiology of maternal opioid use disorder
•Understand pharmacology and use of buprenorphine/naloxone in opioid treatment
•Overview of maternal comprehensive opioid addiction program
•In-depth review of medication initiation and maintenance during pregnancy and postpartum period
•Understand monitoring parameters during initiation and discontinuation
•Review of Neonatal Abstinence Syndrome (NAS) Ramification
Tembele Yangandawele, MD NGPG Family Medicine
No Disclosures
Objectives:
•Review epidemiology of maternal opioid use disorder
•Understand pharmacology and use of buprenorphine/naloxone in opioid treatment
•Overview of maternal comprehensive opioid addiction program
•In-depth review of medication initiation and maintenance during pregnancy and postpartum period
•Understand monitoring parameters during initiation and discontinuation
•Review of Neonatal Abstinence Syndrome (NAS) Ramification
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
